We conducted a prospective study to evaluate the vertebrobasilar system in adults with and without obstructive sleep apnea (OSA). Our study population was made up of 48 patients with OSA and 21 healthy volunteers who served as controls; the OSA patients were subdivided into one group with mild or moderate OSA (n = 22) and another with severe OSA (n = 26). Each participant underwent Doppler ultrasonography three times to measure the diameter of the vertebral artery, the peak systolic velocity (PSV), the resistive index (RI), and the vertebral artery flow volume; the mean of the three measurements was calculated for each patient, for the OSA and control groups, and for various subgroups. No significant differences in vessel diameter, PSV, or RI were seen among any of the subgroups. Overall, the vertebral artery flow volume was slightly, but not significantly, higher in all patients with OSA (206 ml/min) than in the control group (177 ml/min); this difference might reflect the body's daytime response to the chronic apneic events experienced during sleep. The only statistically significant difference we found was in vertebral artery flow volume between the controls and the subgroup with mild or moderate OSA (p = 0.026); no difference was seen between the controls and the patients with severe OSA (p = 0.318). Likewise, no significant difference in any of the four parameters was seen when patients were subclassified by body mass index and arterial oxygen saturation level.
Introduction
Obstructive sleep apnea (OSA) is a common disorder of the upper airway characterized by repeated partial or total cessation of breathing during sleep. 1 Patients with OSA experience repetitive hypoxemia, CO 2 retention, consequent sympathetic activation, and marked blood pressure surges during sleep. Many of these patients are obese and likely to have metabolic dysregulation. Many previous studies have described the association between OSA and neural, hormonal, vascular, inflammatory, and metabolic abnormalities. Studies have shown that a decreased level of nitric oxide metabolites, an increase in the production of superoxide by neutrophils, and an increased level of proinflammatory cytokines are the factors most responsible for the development of vascular system disorders in patients with OSA. 2 Also, a decrease in endothelium-mediated vasodilation was recently shown to cause endothelial dysfunction in patients with OSA. 3 Several population-based epidemiologic studies have found that OSA is associated with cardiovascular diseases such as hypertension, heart failure, and arrhythmias. 2, 3 These data also suggest a strong relationship between sleep-disordered breathing and acute cerebrovascular events such as stroke. 4, 5 For example, in a large-scale cross-sectional study of 6,424 free-living individuals, Shahar et al found that sleep-disordered breathing was associated more strongly with stroke than with coronary artery disease (odds ratio [OR]: 1.58; 95% confidence interval [CI]: 1.02 to 2.46; p = 0.01). 4 In a cross-sectional analysis of approximately 1,500 participants, Arzt et al also found that those with sleep-disordered breathing had a higher risk of stroke (OR: 4.33; 95% CI: 1.32 to 14.24; p = 0.02). 5 Besides stroke imaging, several neuroimaging methods have been used in assessing the cerebral effects of OSA with varying degrees of reliability. Structural neuroimaging studies have been inconsistent in providing evidence of generalized changes in gray matter; these inconsistencies might be related to differences in individual study samples. More reliable findings have been reported with conventional magnetic resonance imaging (MRI) for identifying decreased hippocampal volume and with spectroscopic studies for detecting white-matter dysfunction, particularly in the frontal lobes. In general, the results of these MRI and spectroscopic studies suggest that white-matter abnormalities may be present in selected patients who are at the greatest risk of developing vascular disease as a result of chronic apneic events.
In an animal study, Pae et al showed that intermittent hypoxia damaged the cerebellar cortex and deep nuclei in rats. 6 The principal specific finding in that study was the damage to the Purkinje cells. The authors reported that damage to the cerebellar processes that (1) coordinate upper-airway muscle action with other respiratory musculature or (2) alter sympathetic outflow may similarly contribute to worsening of OSA syndrome. These findings suggest that chronic apneic events cause not only supratentorial brain injury, but also posterior fossa. ischemia.
Doppler ultrasonography is useful in evaluating the vertebral arteries, and it is widely used for the assessment of vertebrobasilar insufficiency. The volume flow rate, which is a parameter of brain perfusion, is a potentially important parameter that combines morphologic and hemodynamic data. Hu et al found a high prevalence of OSA in patients with cerebrovascular ischemia caused by vertebrobasilar artery stenosis. 7 In this article, we describe our prospective study to evaluate various vertebrobasilar parameters in patients with and without OSA. In the English-language literature, we could not find any previously published study regarding the relationship between vertebrobasilar ischemia and OSA.
Patients and methods
A total of 48 consecutively presenting patients with OSA-34 men and 14 women, aged 26 to 69 years (mean: 52)-were enrolled in the study. A group of 21 healthy volunteers without OSA-12 men and 9 women, aged 30 to 55 years (mean: 49)-served as controls. Exclusion criteria included hypertension, coronary artery disease, atrial fibrillation, cerebrovascular disease, end-stage renal disease, cervical spondylosis, and a history of neck surgery.
Polysomnography. All patients were evaluated with full-night polysomnography (Embla S7000 System; Embla; Ottawa, Canada), which is the gold standard for the diagnostic assessment of OSA patients. A minimum of 7 hours of recording time was obtained for each. During recording, surface electrodes were placed to obtain an electroencephalogram at positions C3/A2, C4/A1, O1/ A2, O2/A1; a bilateral electrooculogram; a chin, intercostal, and bilateral anterior tibialis electromyogram; and an electrocardiogram.
Respiration was monitored as follows: airflow was measured with a nasal cannula/pressure transducer system and a surface-mount thermocouple; chest and abdominal efforts were measured with uncalibrated respiratory plethysmographic belts; arterial oxygen saturation (SaO 2 ) was measured with pulse oximetry; snoring sounds were measured with a neck microphone; and body position movements were measured with a mercury gauge.
Sleep recordings were scored according to generally accepted international criteria developed by the American Academy of Sleep Medicine (AASM). 8 In accordance with the AASM guidelines, apnea was defined as a complete cessation of airflow for at least 10 seconds, and hypopnea was defined as either (1) a reduction in airflow of at least 50% for 10 or more seconds or (2) a reduction in breathing of less than 50% associated with 3% desaturation of oxyhemoglobin. The apnea-hypopnea index (AHI) reflects the number of apneic and hypopneic episodes per hour of sleep.
Doppler ultrasonography. All participants also underwent Doppler ultrasonography with a linear transducer (4L10; GE Medical Systems; Waukesha, Wis.). Before the Doppler examination, parameter measurements were taken in the vertebral arteries, and a routine examination of the carotid arteries was performed to document atherosclerosis and to exclude relevant internal carotid stenosis.
The subjects rested in the supine position for 15 minutes before the examination. Both sides were examined. The patient's head was turned slightly to the opposite side each time. The intertransverse (V2) segment of the vertebral artery was visualized by rotating the probe posteriorly from the carotid plane. Duplex measurement of angle-corrected flow velocities was done with the sample volume expanded over the entire vessel diameter. The diameter of the vertebral artery, the peak systolic velocity (PSV), the resistive index (RI), and the vertebral artery flow volume were recorded (figure). Angle correction was performed whenever necessary. The vessel diameter was measured in a magnified B-mode image for better accuracy at the site of the Doppler sample volume. All measurements were performed three times, and an average was calculated.
Subgroup analyses. The entire study population was separated into various subgroups on the basis of the absence or severity of OSA, their body mass index (BMI), and their SaO 2 level:
• Of the 48 patients with OSA, 22 had mild or moderate OSA (AHI: <30) and 26 had severe OSA (AHI: ≥30).
• 22 OSA patients had a BMI of less than 30, and 26 had a BMI of 30 or more.
• 28 participants had an SaO 2 level of less than 80%, and 20 had a level of 80% or higher. 
Results
Subjects' characteristics and their polysomnographic respiratory parameters are shown in table 1.
The mean vertebral artery diameter, PSV, RI, and vertebral artery flow volume according to OSA status are shown in table 2. No statistically significant differences in vertebral artery diameter, PSV, and RI were seen among these groups. However, there was a significant difference in vertebral artery flow volume between the controls and the patients with mild or moderate OSA (p = 0.026). The difference between the controls and the patients with severe OSA was not significant (p = 0.318). Overall, the vertebral artery flow volume in all OSA patients was slightly higher than that of the controls, although not significantly so (206 vs. 177 ml/ min; p = 0.078).
No statistically significant differences in vertebral artery diameter, PSV, RI, and flow volume were noted in the subgroups based on BMI and SaO 2 level, as shown in table 3.
Discussion
Recent research on stroke and hypertension in OSA patients has focused on endothelial dysfunction as a causative factor. 9 A strong relationship exists between nocturnal oxygen desaturation in OSA and carotid intima-media thickness, inflammation, and platelet activation. In OSA patients, studies have shown that cerebral autoregulation is impaired, 9, 10 and carotid intima-media thickness and serum levels of C-reactive protein, interleukin 6, and interleukin 18 are significantly higher than they are in subjects without OSA. 10 In 2007, Minoguchi et al reported that 25% of patients with OSA had silent brain infarctions, compared with only 7% of those in a control group. 11 Four years earlier, Harbison et al noted a high prevalence of prestroke cerebrovascular disease in patients with sleep apnea, suggesting that OSA might lead to stroke. 12 Others have shown that changes in cerebral blood flow velocity during apneic episodes and concomitant alterations of vessel wall tension associated with alternating obstructive apneas and hyperapneas can lead to changes in vascular shear forces and acceleration of micro-and macroangiopathies in the brain. 13, 14 These changes have been demonstrated on neuroimaging, as well. The study by Minoguchi et al demonstrated the presence of subcortical white-matter lesions (i.e., silent brain infarctions) in obese controls and in patients with mild OSA. 11 Among patients with moderate and severe OSA, silent brain infarctions were identified in subcortical white matter (54% of cases), in the basal ganglia and thalamus (43%), and in the brainstem (3%). Their study showed that the ischemic process involves both the supratentorial region and the posterior fossa structures.
In OSA patients, ischemia of the supratentorial region has been studied frequently, but we are not aware of any article that specifically addressed the posterior fossa structures. Although dedicated neuroimaging studies were not the subject of our investigation, they do represent a potential area of future study.
The cerebral vessels in OSA patients have been studied Others have shown that velocities were higher in OSA patients than in controls during most sleep stages 15 and during apneic events. 16 Conversely, velocities were slightly lower in OSA patients during wakefulness. 15 Studies of transcranial Doppler ultrasonography have also demonstrated a diminished vasomotor reactivity among patients with OSA, especially during the morning hours. 17 Moreover, Minoguchi et al found increased cerebral blood flow velocities in children with mild sleep-disordered breathing. 11 To the best of our knowledge, no previously published studies of MRI or Doppler ultrasonography have evaluated the effect of OSA on posterior fossa circulation. The main objective of our study was to evaluate the vertebral arteries, which are commonly imaged by Doppler ultrasonography in patients with ischemia of the posterior circulation.
The mechanism of vertebrobasilar ischemia is a controversial subject. While some authors are convinced that embolism is the major cause (as is the case in internal carotid artery disease), others believe that vertebrobasilar ischemia is primarily a hemodynamic phenomenon based on the reduction in net vertebral artery flow volume. 7, 18 Hemodynamic data obtained by ultrasound investigations of extra-and intracranial vessels include blood flow velocities and calculated pulsatility indices. The volume flow rate, which is a parameter of brain per-fusion, is a potentially important marker that combines morphologic and hemodynamic data.
Duplex ultrasound systems calculate the flow volume as the product of mean flow velocity and the crosssectional area of the vessel. An arbitrary threshold of 200 ml/min has been proposed for net vertebral artery flow volume by the conventional duplex sonographic method; patients with values less than that are prone to become symptomatic with vertebrobasilar ischemia. However, a study by Seidel et al found that values well below 200 ml/min are within the normal range for net vertebral artery flow volume. 18 In our study, the mean total vertebral artery flow volume (sum of the right and left sides) in the entire OSA group was 206 ml/min; our control group, meanwhile, had a mean vertebral artery flow volume of 177 ml/min (table 2) . Although the flow volume in the OSA group was slightly higher, the difference between the OSA groups and the control group was not statistically significant (p = 0.078). However, the patients in our study who had mild or moderate OSA (AHI: <30) showed a higher overall vertebral flow volume than did the control group (p = 0.026). Such a statistically significant increase was not observed in the severe OSA (AHI: ≥30) group (p = 0.318).
The study by Hu et al found that OSA was frequent in patients whose cerebrovascular ischemia was caused by vertebrobasilar artery stenosis. 7 Based on the results of our study, one might expect that net vertebral artery flow volumes would be lower in patients with OSA because of vertebrobasilar stenosis. The fact that there was a significant difference in vertebral artery flow volume between our control group and the group with mild or moderate OSA but no difference between the controls and the group with severe OSA suggests that the former simply represented a chance finding rather than a true difference. Another possible explanation for our findings is that the cerebrovascular systems in our severe OSA group might have adapted to chronic and recurrent hypoxic attacks. As a result, the vertebral artery flow volumes in this group were not significantly different from those of the controls. Patients with mild or moderate OSA might not have an adaptation mechanism. Also, awake-time and sleep-time changes might have dramatic effects on posterior circulation, and therefore the cerebrovascular system in patients with mild or moderate OSA might react by increasing the posterior cerebral circulation, which could explain the significant increase in vertebral artery flow volume in that group compared with the control group.
Our study also showed that BMI and O 2 saturation had no effect on vertebrobasilar parameters.
Most of the physiologic studies performed on our OSA patients were performed while they were asleep. Transcranial Doppler ultrasonography can be performed by attaching the ultrasound probe to the patient's head while he or she is sleeping. However, the Doppler ultrasound component of our study was performed during the early morning on patients who were awake. Therefore, we could not determine the physiologic changes that might occur during apneic periods of sleep; as a result, our finding might represent the daytime effects of chronic apnea. Another drawback of our study was the lack of vertebral artery angiography and posterior fossa neuroimaging studies. Morphologic and functional imaging studies of the posterior fossa especially might be further studied.
In conclusion, we found that patients with OSA had a slightly higher net vertebral artery flow volume than did our healthy controls. Although the difference was not statistically significant, it might reflect the daytime response of the body to the chronic apneic events that OSA patients experience during sleep.
